Delec Científica

The medical center specializes in the treatment of Chronic Lymphocytic Leukemia (CLL), with a focus on innovative therapies combining Bcl-2 inhibitors and monoclonal antibodies. In this Italian city, Delec carried out the Acceptance Test Procedures (ATP) but did not intervene in the previous process.